CEP-37251
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEP-37251, covering 2014-05-12 to 2014-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women [Phase 1]